Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CARDINAL HEALTH INCCAH · Entity 3014 | Director | November 08, 2017 | November 09, 2017 |
| ILLUMINA, INC.ILMN · Entity 3137 | Director | May 21, 2026 | May 22, 2026 |
| LABCORP HOLDINGS INC.LH · Entity 1277 | Director | May 05, 2020 | May 07, 2020 |
| Privia Health Group, Inc.PRVA · Entity 1532 | Director | May 20, 2026 | May 22, 2026 |
| ZimVie Inc.ZIMV · Entity 74112 | Director | March 31, 2025 | April 02, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CARDINAL HEALTH INC
Report date November 08, 2017 · Filed November 09, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 21,044 |
Reported balance
After 2017-11-08 transaction · row 1
1 source rowRow 1 · 2017-11-08 · Grant · Acquired 2,623 · Balance 21,044 F1: Grant of restricted share units that will vest on November 8, 2018, except if the 2018 Annual Meeting of Shareholders is prior to November 8, 2018, then restricted share units will vest on the date of the 2018 Annual Meeting of Shareholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted share units that will vest on November 8, 2018, except if the 2018 Annual Meeting of Shareholders is prior to November 8, 2018, then restricted share units will vest on the date of the 2018 Annual Meeting of Shareholders.
ILLUMINA, INC.
Report date May 21, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,072 |
Reported balance
After 2026-05-21 transaction · row 1
1 source rowRow 1 · 2026-05-21 · Grant · Acquired 2,072 · Balance 2,072 F1: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date.
LABCORP HOLDINGS INC.
Report date May 05, 2020 · Filed May 07, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 312,554.1345 |
Reported balance
After 2020-05-05 transaction · row 1
1 source rowRow 1 · 2020-05-05 · Sale · Disposed 31,250 · Balance 312,554.1345 |
| Common StockSEC Table I · non-derivative | IndirectBy grantor retained annuity trust | 19,542 |
Reported balance
Holding disclosure · report date 2020-05-05 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 19,542 |
Privia Health Group, Inc.
Report date May 20, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par value per shareSEC Table I · non-derivative | Direct | 50,775 |
Reported balance
After 2026-05-20 transaction · row 1
1 source rowRow 1 · 2026-05-20 · Grant · Acquired 8,463 · Balance 50,775 F1: On May 20, 2026, the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders and (ii) the first anniversary of the date of the grant. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 20, 2026, the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.
ZimVie Inc.
Report date March 31, 2025 · Filed April 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Share UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $10.78 | Direct | 42,593.166 |
Reported balance
After 2025-03-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-03-31 · Grant · Acquired 3,710.575 · Balance 42,593.166 F1: The deferred share units were accrued under the ZimVie Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3: Units are to be settled in cash in four annual installments commencing within sixty days after cessation of the reporting person's service as a Director. |
Filing footnotes · ownership attribution and instrument terms
F1: The deferred share units were accrued under the ZimVie Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors.
F2: The Conversion or Exercise Price of Derivative Security is 1-for-1.
F3: Units are to be settled in cash in four annual installments commencing within sixty days after cessation of the reporting person's service as a Director.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 21, 2026 Filed May 22, 2026 21:19 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 2,072 | $144.83 | $300,087.76 |
DisclosureSEC source: 0001110803-26-000121 · form4.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,072 F1 · shares: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. Read SEC document |
| May 20, 2026 Filed May 22, 2026 12:24 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | GrantCommon Stock, $0.01 par value per share | 8,463 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-26-000037 · wk-form4_1779452674.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,775 F1 · shares: On May 20, 2026, the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders and (ii) the first anniversary of the date of the grant. Read SEC document |
| May 21, 2025 Filed May 23, 2025 21:04 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | GrantCommon Stock, $0.01 par value per share | 8,396 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-25-000076 · wk-form4_1748034271.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,312 F1 · shares: On May 21, 2025, the reporting person received 8,396 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2026 annual meeting of stockholders and (ii) the first anniversary of the date of the grant. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:47 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantDeferred Share Units · Derivative | 3,710.575 | $0.00 Strike: $10.78 | $0.00 |
DisclosureSEC source: 0001062993-25-006863 · form4.xml · derivative · entry 1 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,593.166 Underlying: Common Stock · 3,710.575 shares Expires not disclosed F1 · security: The deferred share units were accrued under the ZimVie Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in four annual installments commencing within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in four annual installments commencing within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 15:00 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantDeferred Share Units · Derivative | 2,855.104 | $0.00 Strike: $14.01 | $0.00 |
DisclosureSEC source: 0001062993-25-000043 · form4.xml · derivative · entry 1 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,882.591 Underlying: Common Stock · 2,855.104 shares Expires not disclosed F1 · security: The deferred share units were accrued under the ZimVie Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in four annual installments commencing within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in four annual installments commencing within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:09 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantDeferred Share Units · Derivative | 2,536.461 | $0.00 Strike: $15.77 | $0.00 |
DisclosureSEC source: 0001062993-24-017240 · form4.xml · derivative · entry 1 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,027.487 Underlying: Common Stock · 2,536.461 shares Expires not disclosed F1 · security: The deferred share units were accrued under the ZimVie Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in four annual installments commencing within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in four annual installments commencing within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 20:39 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantDeferred Share Units · Derivative | 2,223.458 | $0.00 Strike: $17.99 | $0.00 |
DisclosureSEC source: 0001062993-24-013317 · form4.xml · derivative · entry 1 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,491.026 Underlying: Common Stock · 2,223.458 shares Expires not disclosed F1 · security: The deferred share units were accrued under the ZimVie Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in four annual installments commencing within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in four annual installments commencing within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| May 22, 2024 Filed May 23, 2024 21:07 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | GrantCommon Stock, $0.01 par value per share | 11,124 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-24-000095 · wk-form4_1716498439.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,916 F1 · shares: On May 22, 2024, the reporting person received 11,124 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2025 annual meeting of stockholders and (ii) the first anniversary of the date of the grant Read SEC document |
| May 15, 2024 Filed May 17, 2024 20:17 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantRestricted Stock Units · Derivative | 14,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-010624 · form4.xml · derivative · entry 2 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,474 Underlying: Common Stock · 14,882 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F4 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F4 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. Read SEC document |
| May 15, 2024 Filed May 17, 2024 20:17 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantDeferred Share Units · Derivative | 500 | $0.00 Strike: $16.80 | $0.00 |
DisclosureSEC source: 0001062993-24-010624 · form4.xml · derivative · entry 1 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,267.568 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The deferred share units were accrued under the ZimVie Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| March 31, 2024 Filed Apr 2, 2024 20:03 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantDeferred Share Units · Derivative | 2,437.538 | $0.00 Strike: $16.41 | $0.00 |
DisclosureSEC source: 0001062993-24-007698 · form4.xml · derivative · entry 1 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,767.568 Underlying: Common Stock · 2,437.538 shares Expires not disclosed F1 · security: The deferred share units were accrued under the ZimVie Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in four annual installments commencing within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in four annual installments commencing within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 21:20 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantDeferred Share Units · Derivative | 2,150.389 | $0.00 Strike: $18.02 | $0.00 |
DisclosureSEC source: 0001062993-24-000191 · form4.xml · derivative · entry 1 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,330.03 Underlying: Common Stock · 2,150.389 shares Expires not disclosed F1 · security: The deferred share units were accrued under the ZimVie Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in four annual installments commencing within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in four annual installments commencing within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| September 30, 2023 Filed Oct 3, 2023 20:01 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantDeferred Share Units · Derivative | 4,117.96 | $0.00 Strike: $9.41 | $0.00 |
DisclosureSEC source: 0001062993-23-018789 · form4.xml · derivative · entry 1 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,179.641 Underlying: Common Stock · 4,117.96 shares Expires not disclosed F1 · security: The deferred share units were accrued under the ZimVie Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in four annual installments commencing within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in four annual installments commencing within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 20:29 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | GrantCommon Stock, $0.01 par value per share | 7,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-23-000151 · wk-form4_1688588962.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,792 F1 · shares: Represents restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan that will become fully vested on the first anniversary of the grant date. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 21:23 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantDeferred Share Units · Derivative | 3,378.378 | $0.00 Strike: $11.47 | $0.00 |
DisclosureSEC source: 0001062993-23-014504 · form4.xml · derivative · entry 1 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,061.681 Underlying: Common Stock · 3,378.378 shares Expires not disclosed F1 · security: The deferred share units were accrued under the ZimVie Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in four annual installments commencing within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in four annual installments commencing within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| May 12, 2023 Filed May 16, 2023 20:42 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantRestricted Stock Units · Derivative | 23,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-011239 · form4.xml · derivative · entry 2 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,592 Underlying: Common Stock · 23,925 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F4 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F4 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. Read SEC document |
| May 12, 2023 Filed May 16, 2023 20:42 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantDeferred Share Units · Derivative | 500 | $0.00 Strike: $10.45 | $0.00 |
DisclosureSEC source: 0001062993-23-011239 · form4.xml · derivative · entry 1 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,683.303 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The deferred share units were accrued under the ZimVie Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:03 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantDeferred Share Units · Derivative | 5,496.454 | $0.00 Strike: $7.05 | $0.00 |
DisclosureSEC source: 0001062993-23-008465 · form4.xml · derivative · entry 1 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,183.303 Underlying: Common Stock · 5,496.454 shares Expires not disclosed F1 · security: The deferred share units were accrued under the ZimVie Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in four annual installments commencing within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in four annual installments commencing within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 21:03 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantDeferred Share Units · Derivative | 4,239.606 | $0.00 Strike: $9.14 | $0.00 |
DisclosureSEC source: 0001062993-23-000236 · form4.xml · derivative · entry 1 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,686.849 Underlying: Common Stock · 4,239.606 shares Expires not disclosed F1 · security: The deferred share units were accrued under the ZimVie Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in four annual installments commencing within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in four annual installments commencing within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 20:04 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantDeferred Share Units · Derivative | 3,855.722 | $0.00 Strike: $10.05 | $0.00 |
DisclosureSEC source: 0001062993-22-020309 · form4.xml · derivative · entry 1 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,447.243 Underlying: Common Stock · 3,855.722 shares Expires not disclosed F1 · security: The deferred share units were accrued under the ZimVie Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: 870.647of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in four annual installments commencing within sixty days after cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: 870.647of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in four annual installments commencing within sixty days after cessation of the reporting person's service as a Director occurs. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 20:03 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantDeferred Share Units · Derivative | 2,399.382 | $0.00 Strike: $16.15 | $0.00 |
DisclosureSEC source: 0001062993-22-015845 · form4.xml · derivative · entry 1 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,591.521 Underlying: Common Stock · 2,399.382 shares Expires not disclosed F1 · security: The deferred share units were accrued under the ZimVie Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: 541.796 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in four annual installments commencing within sixty days after cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: 541.796 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in four annual installments commencing within sixty days after cessation of the reporting person's service as a Director occurs. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 20:33 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | GrantCommon Stock, $0.01 par value per share | 7,425 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020424 · doc4.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,034 F1 · shares: Represents restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan that will become fully vested on the first anniversary of the grant date. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 21:16 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantRestricted Stock Units · Derivative | 10,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-009501 · form4.xml · derivative · entry 3 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,667 Underlying: Common Stock · 10,667 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 21:16 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantDeferred Share Units · Derivative | 500 | $0.00 Strike: $23.44 | $0.00 |
DisclosureSEC source: 0001062993-22-009501 · form4.xml · derivative · entry 2 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,192.139 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The deferred share units were accrued under the ZimVie Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F4 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 21:16 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantDeferred Share Units · Derivative | 1,692.139 | $0.00 Strike: $22.90 | $0.00 |
DisclosureSEC source: 0001062993-22-009501 · form4.xml · derivative · entry 1 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,692.139 Underlying: Common Stock · 1,692.139 shares Expires not disclosed F1 · security: The deferred share units were accrued under the ZimVie Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: 382.096 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in four annual installments commencing within sixty days after the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: 382.096 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in four annual installments commencing within sixty days after the cessation of the reporting person's service as a Director occurs. Read SEC document |
| April 28, 2021 Filed May 1, 2021 01:41 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | GrantCommon Stock, $0.01 par value per share | 7,609 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-21-006549 · dp150371_4-king.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,609 F1 · security: Represents restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan that will become fully vested on the first anniversary of the grant date. Read SEC document |
| May 05, 2020 Filed May 7, 2020 16:05 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | SaleCommon Stock | 31,250 | $160.00 | $5,000,000.00 |
DisclosureSEC source: 0001127602-20-015690 · form4.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312,554.1345 Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 18:40 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Tax withholdingCommon Stock | 24,583 | $131.95 | $3,243,726.85 |
DisclosureSEC source: 0001127602-20-012389 · form4.xml · nonDerivative · entry 2 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343,804.1345 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 18:40 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantCommon Stock | 54,995 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-012389 · form4.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,387.1345 F1 · kind: Shares acquired on March 30, 2020, pursuant to a performance award granted on February 7, 2017, while the reporting person held the position of Chief Executive Officer and President, relating to performance during the three-year period ended December 31, 2019. Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 20:42 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 4,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005600 · form4.xml · derivative · entry 7 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,558 Underlying: Common Stock · 4,236 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 12, 2020. F5 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 12, 2020. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 20:42 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 3,513 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005600 · form4.xml · derivative · entry 6 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,794 Underlying: Common Stock · 3,513 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 12, 2019. F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 12, 2019. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 20:42 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Tax withholdingCommon Stock | 1,894 | $187.51 | $355,143.94 |
DisclosureSEC source: 0001127602-20-005600 · form4.xml · nonDerivative · entry 4 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313,392.1345 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 20:42 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 4,236 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-005600 · form4.xml · nonDerivative · entry 3 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315,286.1345 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 20:42 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Tax withholdingCommon Stock | 1,386 | $187.51 | $259,888.86 |
DisclosureSEC source: 0001127602-20-005600 · form4.xml · nonDerivative · entry 2 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,050.1345 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 20:42 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 3,513 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-005600 · form4.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312,436.1345 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 18:42 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 4,220 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004806 · form4.xml · derivative · entry 4 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,307 Underlying: Common Stock · 4,220 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units vested in three equal annual installments beginning on February 7, 2018 and are now fully vested. F4 · derivative.expiration_date: The Restricted Stock Units vested in three equal annual installments beginning on February 7, 2018 and are now fully vested. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 18:42 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Tax withholdingCommon Stock | 1,252 | $182.33 | $228,277.16 |
DisclosureSEC source: 0001127602-20-004806 · form4.xml · nonDerivative · entry 2 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,923.1345 F3 · kind: Stock withholding to satisfy tax withholding obligations. F2 · balance_after: Amount includes 21.7403 shares acquired on December 31, 2019 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 18:42 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 4,220 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-004806 · form4.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,175.1345 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · balance_after: Amount includes 21.7403 shares acquired on December 31, 2019 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 16:21 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantRestricted Stock Unit · Derivative | 38,570 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-000356 · form4.xml · derivative · entry 1 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,527 Underlying: Common Stock · 38,570 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vest on 1/1/2021. F2 · derivative.expiration_date: The Restricted Stock Units vest on 1/1/2021. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| October 28, 2019 Filed Oct 30, 2019 21:25 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | SaleCommon Stock | 12,352 | $166.21 | $2,053,053.09 |
DisclosureSEC source: 0001127602-19-031280 · form4.xml · nonDerivative · entry 3 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,933.3942 F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. F5 · price: The price of $166.2122 per share represents a weighted average of sales prices ranging from $165.79 to $166.48 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F3 · balance_after: Amount includes 168.7938 shares acquired on June 28, 2019 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. Amount also includes 38,555 shares transferred by the reporting person's grantor retained annuity trust to the reporting person.. Read SEC document |
| October 28, 2019 Filed Oct 30, 2019 21:25 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | SaleCommon Stock | 10,391 | $165.32 | $1,717,831.81 |
DisclosureSEC source: 0001127602-19-031280 · form4.xml · nonDerivative · entry 2 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318,285.3942 F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. F4 · price: The price of $165.3192 per share represents a weighted average of sales prices ranging from $164.79 to $165.77 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F3 · balance_after: Amount includes 168.7938 shares acquired on June 28, 2019 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. Amount also includes 38,555 shares transferred by the reporting person's grantor retained annuity trust to the reporting person.. Read SEC document |
| October 28, 2019 Filed Oct 30, 2019 21:25 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | SaleCommon Stock | 7,434 | $164.16 | $1,220,331.99 |
DisclosureSEC source: 0001127602-19-031280 · form4.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 328,676.3942 F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price of $164.1555 per share represents a weighted average of sales prices ranging from $163.69 to $164.68 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F3 · balance_after: Amount includes 168.7938 shares acquired on June 28, 2019 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. Amount also includes 38,555 shares transferred by the reporting person's grantor retained annuity trust to the reporting person.. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:30 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Tax withholdingCommon Stock | 41,311 | $154.79 | $6,394,529.69 |
DisclosureSEC source: 0001127602-19-014724 · form4.xml · nonDerivative · entry 2 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,386.6004 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:30 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantCommon Stock | 92,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-014724 · form4.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,697.6004 F1 · kind: Shares acquired on April 1, 2019, pursuant to a performance award granted on February 9, 2016, relating to performance during the three-year period ended December 31, 2018. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:44 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantNon-qualified Stock Options · Derivative | 52,300 | $0.00 Strike: $146.59 | $0.00 |
DisclosureSEC source: 0001127602-19-006016 · form4.xml · derivative · entry 7 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,300 Underlying: Common Stock · 52,300 shares Expires 2029-02-11 F6 · security: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan. F7 · derivative.exercise_date: The option vests in three equal installments beginning on the date reflected in this column. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:44 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantRestricted Stock Unit · Derivative | 12,710 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006016 · form4.xml · derivative · entry 6 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,957 Underlying: Common Stock · 12,710 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/12/2020. F5 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/12/2020. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:44 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 3,513 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006016 · form4.xml · derivative · entry 5 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,247 Underlying: Common Stock · 3,513 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/12/19. F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/12/19. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:44 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Tax withholdingCommon Stock | 1,571 | $146.59 | $230,292.89 |
DisclosureSEC source: 0001127602-19-006016 · form4.xml · nonDerivative · entry 2 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,280.6004 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:44 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 3,513 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-006016 · form4.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,851.6004 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 17:11 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 7,544 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005560 · form4.xml · derivative · entry 5 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,760 Underlying: Common Stock · 7,544 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vested in three equal annual installments beginning on 2/9/2017 and are now fully vested. F3 · derivative.expiration_date: The Restricted Stock Units vested in three equal annual installments beginning on 2/9/2017 and are now fully vested. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.